BeStock  
Stocks › Biotechnology › PGEN

Precigen PGEN

US equityMarket cap rank #2871Biotechnology
$4.21 +$0.05 (+1.20%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.24 +0.61%
Open$4.16
Prev close$4.16
Day range$4.07 – $4.36
Volume6.07M
Market cap$1.51B
P/E (TTM)38.3
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings41.3x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average -0.8x

#2442 of 2993 stocks by PE (1 = cheapest)

Price / book19.4x
CheapRich

Near the top of its 5-year range · 80th percentile, 5-year average 11.0x

#5132 of 5330 stocks by PB (1 = cheapest)

Price / sales10.4x
CheapRich

Below its usual level · 28th percentile, 5-year average 69.4x

#4507 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-16x5x25x45xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$4.37
Price vs. fair value-3.7%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 19.40 – 10.99 80% (pricier than usual) #5132 of 5330 (1 = cheapest)
PE 41.27 8.43 -0.84 100% (pricier than usual) #2442 of 2993 (1 = cheapest)
PS 10.37 4.26 69.39 28% (cheaper than usual) #4507 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PGEN.

Sign in to join the discussion.

Scroll to Top